Impact Biomedical uses innovative science to help medical providers improve disease survival rates and impact overall health outcomes.

By leveraging the newest technology and science with strategic partnerships, Impact BioMedical drives mission-oriented research, development, and commercialization of solutions for medical advances in human wellness and healthcare.

Impact BioMedical expands the borders of medical and pharmaceutical science by targeting urgent medical needs.

Additional sciences and applications:

  • Oncology
  • Neurology
  • Inflammatory Disease
  • Sugar Substitute
  • Advanced plastics
  • Immune Supplement
  • OTC Medicine
  • Vaccines
  • Vitamins
  • Antivirals
  • Antimicrobials
  • Natural Treatments
  • Polyphenols
  • Insect and Mosquito Repellent
  • New classes of medicinal chemistry
  • Nanotechnology
  • Probiotics
  • Therapeutic medical foods

Core Assets

LineBacker

LineBacker is a platform of small molecule X-bonded polyphenols.

Stage: Pre-clinical development, with two characterized molecules which can potentially enter phase one studies.

Markets: Neurology, anti-inflammatory, oncology.

Download Sell sheet

Equivir/Nemovir

Equivir/Nemovir technology is a novel blend of FDA Generally Recognized as Safe (GRAS) eligible polyphenols sourced from natural substances which have demonstrated antiviral effects with additional potential application as health supplements or medication.

Stage: Compound development, safety, and stability are complete.

Markets: Global health supplement, antivirals

Available for worldwide licensing, joint venture, and/or co-development agreements.

Download Sell sheet

Laetose

Laetose technology is derived from a unique combination of sugar and inositol, which demonstrates the ability to inhibit the inflammatory and metabolic response of sugar alone.

Stage: Product development, stability, and manufacturing capability are complete.

Markets: Sugar substitute with potential to reduce calories, glycemic index, and glycemic load

Available for worldwide licensing, joint venture, and/or co-development agreements.

Download Sell sheet

3F

3F is a unique formulation of specialized ingredients from botanical sources with demonstrated effect as an insect repellent and an antimicrobial.

Stage: Contingent on regulatory approval, the three formulations have been characterized and are now available for development and/or as material additives to manufacturing processes.

Markets: Additive as fragrance, anti-microbial, repellents

Available for worldwide licensing, joint venture, and/or co-development agreements.

Download Sell sheet

Impact Biomedical participates in key research projects and collaborations to facilitate breakthroughs in treatment protocols. Click below to learn how it is quickly becoming a global leader in the future of biotech.